首页> 美国卫生研究院文献>The American Journal of Pathology >Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation.
【2h】

Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation.

机译:对VLA-4和LFA-1的双重抑制最大程度地抑制了皮肤迟发型超敏反应诱导的炎症。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lymphocytes express surface receptors that mediate adhesion to endothelial cells and control T cell migration into inflammatory sites. Lymphocyte VLA-4 and LFA-1 mediate adhesion to cytokine-activated endothelium, but the contribution of these molecules to in vivo migration and lymphocyte mediated inflammation is not clear. Here we show that both VLA-4 and LFA-1 contribute to not only lymphocyte adhesion but to in vivo lymphocyte migration in the rat and that nearly complete inhibition of lymphocyte accumulation is observed when both integrins are blocked. Furthermore, inhibition of delayed-type hypersensitivity-induced inflammation, as quantified by skin induration and fibrin deposition, is observed with either anti-VLA-4 or anti-LFA-1, but much stronger inhibition is observed with a blockade of both integrins. Thus, dual inhibition of the VLA-4 and LFA-1 pathways is required for a maximal anti-inflammatory effect in some types of T cell-mediated inflammation.
机译:淋巴细胞表达表面受体,该表面受体介导与内皮细胞的粘附并控制T细胞向炎症部位的迁移。淋巴细胞VLA-4和LFA-1介导细胞因子激活的内皮细胞的粘附,但这些分子对体内迁移和淋巴细胞介导的炎症的贡献尚不清楚。在这里,我们显示VLA-4和LFA-1不仅对大鼠的淋巴细胞粘附有贡献,而且对大鼠体内的淋巴细胞迁移也有贡献,并且当两个整合素均被阻断时,观察到淋巴细胞积累的几乎完全抑制。此外,用抗VLA-4或抗LFA-1均可观察到对延缓型超敏性诱导的炎症的抑制作用(通过皮肤硬结和纤维蛋白沉积来量化),但在同时抑制两种整联蛋白的情况下,观察到的抑制作用要强得多。因此,在某些类型的T细胞介导的炎症中,要发挥最大的消炎作用,就必须双重抑制VLA-4和LFA-1途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号